Search results
GlaxoSmithKline Pharma India posts higher Q4 adjusted profit on strong sales
Reuters via Yahoo Finance· 5 hours agoRevenue from operations rose 18% to 9.30 billion rupees, led by a 12% growth in its generic medicines portfolio which the company attributed to key focus ...
Patent Peril: 3 Stocks at Risk From the FTC's Drug Crusade
InvestorPlace· 1 day agoSeveral drug stocks are at risk as the Federal Trade Commission is going after pharmaceutical...
Health Care Roundup: Market Talk
The Wall Street Journal· 3 hours ago0655 GMT – Roche’s latest weight-loss drug candidate data suggests it has the potential to credibly compete against peers Novo Nordisk and Eli Lilly in...
GoodRx and Kroger partner to slash generic drug costs By Investing.com
Investing.com· 2 days agoThis collaboration is set to take effect starting June 1, 2024, when customers presenting a GoodRx...
Americans Are Spending the Most Money on These 25 Prescription Drugs
Healthline· 1 day agoThe diabetes and weight loss medication semaglutide (Ozempic, Wegovy, and Rybelsus) topped the list....
Choosing sunscreen: New study finds most items tested offer poor protection or contain harmful...
Staten Island Advance· 3 days agoThe Environmental Working Group (EWG) evaluated 1,700 SPF products in its 18th annual assessment,...
FTC Continues to ‘Dispute’ Orange Book Device Patent Listings, But Still No Antitrust Enforcement |...
JD Supra· 1 day agoOver the last eight months, the US Federal Trade Commission (FTC) has focused on what it characterizes as “improper” Orange Book listings and the impacts of such listings on generic ...
Generation Bio Co. (GBIO) Reports Q1 Loss, Tops Revenue Estimates
Zacks· 4 days agoThis quarterly report represents an earnings surprise of -211.11%. Over the last four quarters, the company has surpassed consensus EPS estimates two times. , which belongs ...
3 Magnificent Stocks That Are Passive Income Machines
The Motley Fool via AOL· 3 days agoLast year, the company spun off its generic and biosimilars business, Sandoz, in order to focus more on growth. And...higher than the $43.5 billion it reported ...
FTC warns pharma companies it means business with its Orange Book listing policy | JD Supra
JD Supra· 2 days agoLast September, the Federal Trade Commission (FTC) promulgated a “policy statement” entitled “Statement Concerning Brand Drug Manufacturers’ Improper Listing of Patents in ...
